Image for 2019 Neuropsychotropic Drug Therapy

On-Demand | Sexual & Reproductive Health Drug Therapy 2020: Osteoporosis

Osteoporosis

This module will review the risks and benefits of denosumab, bisphosphonates and estrogen.

Objectives for Learning Outcomes

At the conclusion of this activity, participants will be better able to:

  1. Understand the risks of Denosumab, particularly hypocalcemia and rapid rebound bone loss.
  2. Describe the effectiveness of bisphosphonates as related to duration of use.
  3. Learn the benefits of estrogen in recently postmenopausal women.

Additional Information

Format: 
Online
Video
Course summary
Maximum credit available: 
  • 1.20 Contact hours
  • 1.20 Pharmacology hours at the advanced practice level
Available: 
06/19/2020
Expires: 
06/19/2024
Cost:
$20.00

Susan Ott, MD
Professor of Medicine, UW Medicine

Professional Credit

ANCC logo. Accreditation Information 

Available Credit

  • 1.20 Contact hours
  • 1.20 Pharmacology hours at the advanced practice level

Price

Cost:
$20.00
Please login or create account to take this course.

For assistance, please contact the Registration Manager at 206-543-1047 orcne@uw.edu.

Required Hardware/software